PNPLA3 and metabolic dysfunction-associated steatotic liver disease: Sun et al. assessed the effect of PNPLA3 genotypes on biomarkers of renal tubular injury and glomerular function in 217 NAFLD patients who had either normal or abnormal ALT levels [54].